Page last updated: 2024-11-02

oxophenylarsine and Neoplasms

oxophenylarsine has been researched along with Neoplasms in 1 studies

oxophenylarsine: inhibits protein-tyrosine-phosphatase
phenylarsine oxide : An arsine oxide derived from phenylarsine.

Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.

Research Excerpts

ExcerptRelevanceReference
"Phenylarsine oxide (PAO) has anticancer potential but it is considered as a toxic agent."1.56Melatonin triggers the anticancer potential of phenylarsine oxide via induction of apoptosis through ROS generation and JNK activation. ( Cui, ZG; Feng, QW; Inadera, H; Li, JL; Li, ML; Li, YL; Muhammad, JS; Sun, L; Zakki, SA, 2020)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Zakki, SA1
Muhammad, JS1
Li, JL1
Sun, L1
Li, ML1
Feng, QW1
Li, YL1
Cui, ZG1
Inadera, H1

Other Studies

1 other study available for oxophenylarsine and Neoplasms

ArticleYear
Melatonin triggers the anticancer potential of phenylarsine oxide via induction of apoptosis through ROS generation and JNK activation.
    Metallomics : integrated biometal science, 2020, 03-01, Volume: 12, Issue:3

    Topics: Antineoplastic Agents; Antioxidants; Apoptosis; Arsenicals; Cell Line, Tumor; Enzyme Activation; Enz

2020